News
Active Startup: Laurent Pharma
![](/research/files/research/styles/fullwidth_breakpoints_theme_moriarty_small_1x/public/channels/image/picture15.png?itok=InzHS5xW×tamp=1697037794)
Published: 10 October 2019
Business Snapshot
Company has developed a clinical stage, orally-active drug candidate with the potential to modulate the immuno-inflammatory response in cystic fibrosis patients.
Target Markets
Cystic fibrosis
Intellectual Property
Patents around the world
Founder
Danuta Radzioch, Radu Pislariu